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lesions can be addressed by this technique thereby reducing the
cost, as a single stent is sufﬁcient and also, the amount of metal at
the bifurcation is reduced, thereby reducing the incidence of rest-
enosis. To conclude TAP is a safe, easy, and cost effective techni-
que that can be used to address most of the bifurcation lesions.
On treatment platelet reactivity in post
percutaneous coronary intervention
patients on thienopyridine drugs:
A six-month outcomes study
Madhavi Rodda *, Rajasekhar Durgaprasad,
Vanajakshamma Velam, Ravikanth Amsala,
Kapil Challa, Sowjenya Gopal
Department of Cardiology, Sri Venkateshwara Institute of Medical
Sciences (SVIMS), Tirupati, Andhra Pradesh, India
Background: In the present era of percutaneous coronary inter-
vention (PCI) dual antiplatelet therapy plays a pivotal role. How-
ever there exists inter individual variability in response to
antiplatelet therapy. Thus, monitoring antiplatelet therapy
becomes vital and may identify poor responders who would ben-
eﬁt from the change in therapy.
Objectives: We sought to identify the efﬁcacy of thienopyridine
antiplatelet drugs in post PCI patients, by using AggreGuide A-100
Platelet Aggregometer, point of care device developed to monitor
platelet aggregation using laser scattering technique.
Methods: This prospective, single-center study, includes patients
who received thienopyridine antiplatelet drugs after PCI during
May 2014–January 2015. In these patients, platelet aggregation
inhibition was evaluated from the whole blood sample using
AggreGuide A-100 and expressed in terms of platelet activity index
– PAI. Patients were labelled as poor responders (high on treatment
platelet reactivity) if the PAI was more than 5. Genetic polymorph-
isms of ABCB1 gene were studied in Clopidogrel group.
Results: A total of 405 patients were enrolled in this study. Among
them 109 (26.9%) were female and 296 (83.1%) were males, 108
(26.7%) underwent primary PCI and 297 (83.7%) underwent elective
PCI. At the discretion of treating physician 221 (54.6%), 111 (27.4%),
and 73 (18%) patients received Clopidogrel, Prasugrel, and Tica-
grelor, respectively. It is found that therapy was ineffective
(PAI > 5) in 73 (16%) patients of which 52, 8, and 5 were in Clopido-
grel, Prasugrel, and Ticagrelor groups, respectively. Cumulatively,
there was high PAI in females and those who underwent primary
PCI. In the Clopidogrel group those with additional Cilostazol were
having low PAI ( p < 0.05). Bleeding complicationswere observed in
3, 9, and 3 patients of Clopidogrel, Prasugrel, and Ticagrelor groups,
respectively. Four patients in Clopidogrel group had reinfarction.
Antiplatelet therapy was optimised in those with high PAI.
Conclusion: It is found that there is high resistance to antiplatelet
drugs (especially Clopidogrel), and thus monitoring individual's
platelet reactivity and optimising therapy based on it, should
become anewstandard-of-care for patients on antiplatelet therapy.
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Background: Rapid risk stratiﬁcation of the patient with acute
chest pain is essential to select the best management. Although
culprit lesions in STEMI cluster in the proximal coronary arteries,
their relationship to bifurcations and curvatures, where blood ﬂow
is disturbed, is unknown.
Objective: We investigated the value of the ECG at ﬁrst medical
contact to determine location and size of the ischemic myocardial
area and thereby severity of risk. We also hypothesized that (a)
culprit lesions are mostly localized to areas with disturbed ﬂow,
e.g. distal to bifurcations and curvatures and (b) the distribution of
culprit lesions in the left coronary artery (LCA) and right coronary
artery (RCA) and resulting infarct size are related to the location of
bifurcations and curvatures.
Methods: In patients with ST elevation myocardial infarction
(STEMI), ECG ﬁndings were correlated with the coronary angio-
gram. Using ST-segment deviation patterns the location of the
coronary culprit lesion was predicted and also the size of the
myocardium at risk. By quantitative coronary angiography,
the distances from the vessel ostium, major bifurcations, and
major curvatures to the culprit lesion were measured in 104
patients.
Results: Correct coronary culprit artery identiﬁcation was possible
in 96% of the patients and this wasmost accurate in localization of
culprit lesion in the proximal part of the coronary arteries. Culprit
lesions were located within 20 mm of a bifurcation in 77% of
patients and closer to the bifurcation in the LCA compared with
the RCA (10.13  7.09 vs 18.49  17.16 mm, p = 0.01). Of RCA culprit
lesions, 53% were located within 30 mm of a major curvature.
Compared with those in the RCA, culprit lesions in the LCA were
located more proximally (19.28  10.27 vs 28.77  20.65 mm,
p < 0.01) and were associated with larger myocardial infarctions
as assessed by CK-MB (139.5  139.4 vs 89.2  93.9 unit/L, p = 0.03),
and lower ejection fractions (39.58  7.0% vs 45.16  8.75%,
p = 0.001).
Conclusions: Admission ECG gives adequate insight regarding the
infarct related artery and the location of the lesion in the culprit
vessel. In patients with STEMI, culprit lesions are frequently
located immediately distal to bifurcations and in proximity to
major curvatures where disturbed ﬂow is known to occur. This
supports the role of wall shear stress in the pathogenesis of STEMI
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Background: Uric acid is the end product of nucleotide metabo-
lism. Serum uric acid when elevated is diagnostic of gout
and is a stress marker in hypertension. The correlation of serum
uric acid with coronary artery disease has been evaluated
though in small number cohort. Present study aims to correlate
the serum uric acid with the severity of CAD and as a marker of
CAD.
Materials andmethods: A total of 470 patients consecutively have
been enrolled into the study. The patients with already a diag-
nosis of gout, on long term use of thiazides and those responsible
for elevated serum urate levels were excluded from the study.
The patients enrolled underwent coronary angiography after
informed and written consent. Based on the results of CAG the
patients were divided into two groups, CAD (n = 350) and control
group (n = 120). The severity of CAD was assessed by modiﬁed
Gensini score.
Results: Mean age of presentation in CAD group was 53.72
 10.38 yrs and in controls was 49.60  9.82 yrs ( p < 0.0001). Males
in total cohort were 331 (70.43%). Hypertensives 226 vs 82 ( p = 0.54),
diabetics (161 vs 30, p = 0.60), smokers (209 vs 48, p = 0.64),
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